Finance

Beta
Lists
ELTP:OTCMKTS
Elite Pharmaceuticals, Inc. Common Stock
$0.39
-3.40%
(-0.014) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTP...
Open
$0.40
High
$0.41
Low
$0.38
Mkt. cap
416.04M
Avg. vol.
620.08K
Volume
721.88K
P/E ratio
9.98
52-wk high
$0.82
52-wk low
$0.33
EPS
$0.04
Beta
0.37
Shares outstanding
1.08B
No. of employees
68
Open
$0.40
High
$0.41
Low
$0.38
Mkt. cap
416.04M
Avg. vol.
620.08K
Volume
721.88K
P/E ratio
9.98
52-wk high
$0.82
52-wk low
$0.33
EPS
$0.04
Beta
0.37
Shares outstanding
1.08B
No. of employees
68
News stories
From sources across the web
About Elite Pharmaceuticals, Inc. Common Stock
CEO-
Employees68
Founded1997
HeadquartersNorthvale, New Jersey, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
32.00M
40.21M
36.32M
31.59M
Cost of goods sold
14.70M
12.99M
22.25M
18.64M
Cost of revenue
14.70M
12.99M
22.25M
18.64M
Research and development expenses
2.04M
1.67M
1.39M
1.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.03M
3.40M
4.03M
2.47M
Operating expense
4.54M
5.53M
5.86M
3.94M
Total operating expenses
19.24M
18.51M
28.11M
22.58M
Operating income
12.76M
21.70M
8.21M
9.01M
Other non operating income
8.30M
-22.11M
7.55M
11.82M
EBT including unusual items
19.27M
-564.21K
15.69M
20.83M
EBT excluding unusual items
20.88M
-564.21K
15.69M
20.83M
Income tax expense
2.27M
5.32M
1.99M
2.24M
Effective tax rate
11.80%
-942.99%
12.67%
10.75%
Other operating expenses
-
-
-
-
Net income
17.00M
-5.88M
13.70M
18.59M
Net profit margin
53.12%
-14.63%
37.73%
58.86%
Earnings per share
-
-
-
-
Interest and investment income
4.56K
4.54K
4.92K
83.60K
Interest expense
-188.84K
-158.93K
-82.47K
-80.20K
Net interest expenses
-184.28K
-154.38K
-77.55K
3.40K
Depreciation and amortization charges
409.86K
394.89K
394.86K
388.14K
EBITDA
13.17M
22.09M
8.61M
9.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more